Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative II-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative II

Published:2015 Issue:4 Volume:18 Page:356
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Kim Sung-Bae¹,Kok Yau Tsz²,Thuan Tran Van³,Chao Tsu-Yi⁴,Shen Zhen Zhou⁵

Affiliation:

1. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

2. Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.

3. Medical Oncology, National Cancer Hospital, Hanoi, Vietnam.

4. Division of Hematology/Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

5. Department of Breast Surgery, Shanghai Fudan University Cancer Hospital, Shanghai, China.

Funder

SANOFI AVENTIS

Publisher

Korean Breast Cancer Society

Subject

Cancer Research,Oncology

Link

https://synapse.koreamed.org/pdf/10.4048/jbc.2015.18.4.356

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-Induced Toxicities and Their Associations with Clinical and Non-Clinical Factors among Breast Cancer Patients in Vietnam;CURR ONCOL;2022

2. Chemotherapy-Induced Toxicities and Their Associations with Clinical and Non-Clinical Factors among Breast Cancer Patients in Vietnam;Current Oncology;2022-10-31

3. Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases;Bulletin du Cancer;2021-03

4.

Effects of Chemotherapy on Serum Lipids in Chinese Postoperative Breast Cancer Patients

;Cancer Management and Research;2020-09

5. Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers;Acta Pharmaceutica Sinica B;2019-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3